Standard lab reference ranges are built from sick-population averages. A "normal" fasting glucose of 99 mg/dL is one point from prediabetes. A "normal" ApoB of 130 mg/dL is driving atherosclerosis. Longevity medicine doesn't accept "normal" — it targets optimal. This panel covers every marker that predicts healthspan and lifespan, with the numbers that separate aging well from aging fast.
Why "Normal" Ranges Are Lying to You
When your doctor says your bloodwork is "normal," they mean your values fall within the laboratory reference range. Those ranges are derived from the local population — which, in most Western countries, is a population where 42% are obese, 38% are prediabetic, and the majority have at least one chronic condition by age 60.
"Normal" means you're not detectably sick compared to an already sick population. It doesn't mean you're optimized. It doesn't mean you're aging well. It means you haven't crossed the threshold where insurance pays for a diagnosis.
Longevity-focused bloodwork asks a different question: not "Am I diseased?" but "Am I optimized for the longest possible healthspan?" The optimal ranges below are narrower than standard lab ranges — sometimes dramatically so. That's the point. They're derived from populations with the lowest all-cause mortality, the best cardiovascular outcomes, and the slowest biological aging rates.
Tier 1: The Non-Negotiables
These are the markers that every longevity physician orders first. If you do nothing else, test these quarterly.
Metabolic Health
| Marker | Standard "Normal" | Optimal for Longevity | Why It Matters |
|---|---|---|---|
| Fasting Glucose | 70–99 mg/dL | <85 mg/dL | Above 85: insulin resistance is already developing, even if HbA1c looks fine |
| Fasting Insulin | 2.6–24.9 µIU/mL | <5 µIU/mL | The single best early marker of metabolic dysfunction. Above 10: insulin resistance is present |
| HbA1c | <5.7% | <5.2% | 90-day glucose average. 5.4–5.6% is "normal" but already shows glycation damage accumulating |
| HOMA-IR | <2.5 (calculated) | <1.0 | Calculated: (fasting glucose × fasting insulin) / 405. The most sensitive insulin resistance index |
| Triglycerides | <150 mg/dL | <80 mg/dL | Marker of carbohydrate metabolism and visceral fat. Below 80 correlates with metabolic health |
Most standard panels test fasting glucose but not fasting insulin. This is a massive blind spot. Insulin resistance develops 10–15 years before glucose rises — your body compensates by producing more insulin to keep glucose "normal." By the time glucose is elevated, the damage has been accumulating for over a decade. Fasting insulin catches the dysfunction when it starts, not when it's become irreversible. If you add one test to your standard panel, make it this one.
Cardiovascular Risk
| Marker | Standard "Normal" | Optimal for Longevity | Why It Matters |
|---|---|---|---|
| ApoB | <130 mg/dL | <80 mg/dL (ideally <60) | Counts every atherogenic particle. Superior to LDL-C for predicting cardiovascular events |
| Lp(a) | <50 nmol/L | <30 nmol/L | Genetically determined. Elevated = independent CVD risk. Test once — it doesn't change |
| Non-HDL Cholesterol | <160 mg/dL | <100 mg/dL | Total cholesterol minus HDL. Captures all atherogenic lipoproteins in one number |
| Triglyceride/HDL Ratio | — | <1.0 (ideally <0.8) | Proxy for insulin resistance and small dense LDL. Above 2.0: metabolic syndrome territory |
ApoB deserves its own explanation. Standard cholesterol panels report LDL-C — the amount of cholesterol carried by LDL particles. But cardiovascular disease isn't driven by the cholesterol itself. It's driven by the particles that carry it. ApoB counts those particles directly. Every VLDL, IDL, LDL, and Lp(a) particle has exactly one ApoB protein on its surface. ApoB gives you the total atherogenic particle count.
Why this matters: two people can have the same LDL-C but vastly different ApoB levels. If your LDL-C is 100 mg/dL but carried by many small dense particles, your ApoB could be 120+ and your actual cardiovascular risk is high. If it's carried by fewer large buoyant particles, ApoB could be 70 and risk is low. LDL-C misses this distinction. ApoB doesn't.
Peter Attia, Allan Sniderman, and the European Atherosclerosis Society have all argued that ApoB should replace LDL-C as the primary lipid target. The data supports them. If your doctor tests only LDL-C, you're getting an approximation when you could be getting the real number.
Inflammation
| Marker | Standard "Normal" | Optimal for Longevity | Why It Matters |
|---|---|---|---|
| hs-CRP | <3.0 mg/L | <0.5 mg/L (below 1.0 at minimum) | General inflammatory burden. Above 1.0: chronic inflammation accelerating epigenetic aging |
| Homocysteine | 5–15 µmol/L | <8 µmol/L | Cardiovascular risk, cognitive decline, methylation status. Above 12: significantly elevated risk |
hs-CRP (high-sensitivity C-reactive protein) is the single best available marker of systemic inflammation. It's produced by the liver in response to inflammatory cytokines — IL-6, TNF-α — released by immune cells, senescent cells, and damaged tissues. Chronic low-grade inflammation ("inflammaging") is now understood to drive most age-related diseases: atherosclerosis, neurodegeneration, sarcopenia, cancer promotion.
A hs-CRP above 3.0 mg/L triples cardiovascular risk compared to below 1.0 mg/L. But even values of 1.0–3.0 are associated with accelerated biological aging in epigenetic clock studies. The target isn't just "low risk" — it's minimal inflammatory load.
hs-CRP spikes acutely with any infection, injury, or surgery — it can go from 0.3 to 50+ during a cold. A single elevated reading means nothing on its own. The value is in the trend: consistent readings above 1.0 across multiple draws (at least 2–3 over several months) indicate chronic inflammation worth investigating. Don't panic over one high result. Do investigate a pattern.
Tier 2: The Advanced Panel
These markers separate surface-level bloodwork from a real longevity assessment. Most standard physicians don't order them. Most longevity physicians consider them essential.
Aging-Specific Biomarkers
| Marker | What It Measures | Optimal Range | Why It Matters |
|---|---|---|---|
| GDF-15 | Cellular stress and mitochondrial dysfunction | <600 pg/mL (under 65); <1,200 pg/mL (over 70) | Strongest single predictor of all-cause mortality independent of age. Integrates mitochondrial health, DNA damage, and inflammatory load into one number |
| Cystatin C | Kidney function (superior to creatinine) | <0.8 mg/L | Not influenced by muscle mass like creatinine. Rising cystatin C predicts accelerated biological aging and cardiovascular mortality |
| DHEA-S | Adrenal reserve and hormonal aging | Age-dependent; top quartile for your age | Peaks at 25, declines steadily. Low DHEA-S predicts frailty, cognitive decline, and all-cause mortality |
| IGF-1 | Growth hormone axis / tissue repair capacity | 100–180 ng/mL (sweet spot varies by age) | Too low: impaired repair, sarcopenia. Too high: associated with cancer risk. The optimal zone is moderate, not maximal |
GDF-15: The Biomarker You've Never Heard Of
Growth Differentiation Factor 15 is emerging as potentially the single most informative longevity biomarker available through standard blood testing. It's a stress-responsive cytokine produced when cells experience mitochondrial dysfunction, DNA damage, oxidative stress, or chronic inflammation.
What makes GDF-15 different from other markers: it integrates multiple aging mechanisms into one number. hs-CRP measures inflammation. Fasting insulin measures metabolic function. Cystatin C measures kidney aging. GDF-15 reflects all of them — it rises when any major aging pathway is accelerated, making it a composite readout of your overall cellular stress burden.
The data is striking. GDF-15 independently predicts cardiovascular mortality, cancer risk, and all-cause death. In the Framingham Heart Study, participants in the highest GDF-15 quartile had a significantly elevated risk of death from any cause compared to those in the lowest quartile, even after adjusting for every other risk factor.
It rises naturally with age — that's expected. What matters is whether your level is above or below the median for your age. Being in the lower quartile for your age cohort is where the longevity benefit concentrates.
Hormonal Panel
| Marker | Standard "Normal" (Males) | Optimal for Longevity (Males) | Why It Matters |
|---|---|---|---|
| Total Testosterone | 264–916 ng/dL | 500–900 ng/dL | Below 400: accelerated sarcopenia, metabolic decline, cognitive impairment. But chasing maximum isn't the goal either |
| Free Testosterone | 5.0–21.0 ng/dL | 10–20 ng/dL | What's actually bioavailable. SHBG rises with age, trapping more testosterone. Total can look fine while free is tanked |
| Estradiol (Males) | 8–43 pg/mL | 20–35 pg/mL | Too low: bone loss, cognitive issues. Too high: gynecomastia, water retention. Both extremes are problematic |
| TSH | 0.45–4.5 mIU/L | 0.5–2.0 mIU/L | Above 2.5: subclinical hypothyroidism may be present. Thyroid decline accelerates metabolic aging |
| Free T4 | 0.8–1.7 ng/dL | 1.0–1.5 ng/dL | Active thyroid hormone. Low-normal with elevated TSH = subclinical hypothyroidism |
Nutrient Status
| Marker | Standard "Normal" | Optimal for Longevity | Why It Matters |
|---|---|---|---|
| Vitamin D (25-OH) | 30–100 ng/mL | 40–60 ng/mL | Below 30: immune dysfunction, bone loss, increased cancer risk. Most adults are deficient. Supplement to target. |
| Ferritin | 12–300 ng/mL (males) | 40–100 ng/mL | Below 40: iron deficiency. Above 200: iron overload risk, oxidative damage. The standard "normal" range is absurdly wide |
| Vitamin B12 | 200–900 pg/mL | >500 pg/mL | Below 400: functional deficiency possible even within "normal" range. Critical for methylation and neurological function |
| RBC Magnesium | 4.2–6.8 mg/dL | 5.5–6.5 mg/dL | Serum magnesium is nearly useless — body maintains serum levels by depleting tissues. RBC magnesium reveals true cellular status |
| Omega-3 Index | — | >8% | EPA+DHA as % of red blood cell membrane. Below 4%: highest risk zone. Above 8%: cardioprotective. Most Westerners are 3–5% |
Tier 3: The Deep Dive
These are for the committed optimizer running a comprehensive longevity program. Not everyone needs these, but they provide resolution that the basic panel can't.
Organ Function (Beyond Standard)
- ALT (Alanine Aminotransferase): Standard liver marker, but in the longevity context, a rising ALT alongside elevated glucose and insulin signals non-alcoholic fatty liver disease (NAFLD) — present in 25–30% of Western adults and a major accelerant of metabolic aging. Optimal: <20 IU/L (standard allows up to 56).
- GGT (Gamma-Glutamyl Transferase): Beyond liver function, elevated GGT independently predicts cardiovascular mortality and metabolic syndrome. Optimal: <25 IU/L for males, <20 IU/L for females.
- Uric Acid: Not just a gout marker. Elevated uric acid (>6.0 mg/dL) is associated with insulin resistance, hypertension, kidney disease, and cardiovascular risk. Optimal: 3.5–5.5 mg/dL.
Advanced Inflammatory and Immune Markers
- Fibrinogen: Coagulation factor and acute-phase reactant. Chronically elevated (>400 mg/dL) indicates inflammatory and prothrombotic states associated with accelerated vascular aging. Optimal: 200–300 mg/dL.
- Complete Blood Count with Differential: Red cell distribution width (RDW) is emerging as an aging biomarker — elevated RDW predicts mortality independent of anemia. Neutrophil-to-lymphocyte ratio (NLR) reflects immune aging and systemic inflammation. Optimal NLR: <2.0.
- LP-PLA2: Lipoprotein-associated phospholipase A2 — directly measures vascular inflammation within arterial walls, unlike hs-CRP which measures systemic inflammation. Elevated LP-PLA2 with low hs-CRP means the inflammation is concentrated in your vasculature. Optimal: <200 ng/mL.
The Complete Panel: What to Order
Essential Longevity Panel (Order Quarterly)
- Fasting glucose
- Fasting insulin
- HbA1c
- Comprehensive metabolic panel (CMP)
- Lipid panel with ApoB
- Lp(a) — once only (genetically fixed)
- hs-CRP
- Homocysteine
- CBC with differential
- Thyroid panel (TSH, Free T4, Free T3)
Advanced Longevity Panel (Order Every 6 Months)
- Everything in the Essential Panel, plus:
- GDF-15
- Cystatin C
- DHEA-S
- IGF-1
- Testosterone (total + free) / Estradiol
- Vitamin D (25-OH)
- Ferritin
- Vitamin B12
- RBC Magnesium
- Omega-3 Index
- Uric acid
- GGT
- Fibrinogen
Annual Deep Dive
- Everything above, plus:
- LP-PLA2
- Advanced lipid panel (particle number/size — NMR LipoProfile)
- Cortisol (AM fasted)
- Sex hormone binding globulin (SHBG)
- Biological age test (TruAge, GrimAge, DunedinPACE)
- Coronary artery calcium (CAC) score — imaging, not blood (every 3–5 years if baseline is 0)
How to Get These Tests
Most standard physicians will order the essential panel without pushback — they just don't order fasting insulin, ApoB, or hs-CRP by default. Ask specifically. The advanced markers (GDF-15, cystatin C, LP-PLA2) may require a longevity-focused physician or direct-to-consumer lab.
Direct-to-consumer options: Services like InsideTracker, Marek Health, and OwlHealth allow you to order specific panels without a physician gatekeeper. This is useful for markers your doctor won't order, but these services typically don't accept insurance.
Cost reality: The essential panel through insurance: $0–50 copay. The advanced panel out-of-pocket through a direct lab: $300–600. The annual deep dive with biological age testing: $800–1,500. This is an investment, and it's worth being honest about what you'll actually do consistently rather than ordering everything once and never following up.
Reading Your Results: The Decision Framework
| Pattern | What It Suggests | First Intervention |
|---|---|---|
| Fasting insulin >7, glucose "normal," TG/HDL >1.5 | Early insulin resistance (glucose hasn't risen YET) | Carbohydrate reduction, time-restricted eating, exercise. Retest in 90 days. |
| ApoB >100, LDL-C "normal" | High particle count with small dense LDL — invisible on standard lipid panel | Discuss statin or PCSK9 inhibitor with physician. Diet alone often insufficient for high particle count. |
| hs-CRP >1.5, all else normal | Chronic low-grade inflammation — source needs identification | Gut health assessment, dental evaluation, sleep quality, visceral fat. hs-CRP is the alarm, not the diagnosis. |
| GDF-15 >1,200, age <65 | Accelerated cellular aging — mitochondrial dysfunction likely | Full workup: cardiac evaluation, cancer screening, mitochondrial support (CoQ10, NAD+ precursors, exercise). |
| Low DHEA-S, low free T, high SHBG | Hormonal aging outpacing chronological age | Sleep optimization, stress management, body composition. If persistent, evaluate with endocrinologist. |
| Ferritin >200, ALT rising, insulin rising | Early metabolic syndrome with possible fatty liver | Liver ultrasound, aggressive metabolic intervention. This pattern predicts type 2 diabetes. |
Testing Frequency: The Protocol
Bloodwork is only useful if you're tracking trends, not snapshots. A single draw tells you almost nothing — it could reflect last night's poor sleep, yesterday's workout, or a subclinical infection you didn't know about. The pattern across multiple draws is what matters.
- Quarterly: Essential panel. This cadence catches metabolic shifts before they become chronic. Align with seasonal changes if possible — metabolic markers shift with activity patterns.
- Every 6 months: Advanced panel. Hormones and specialized markers change slowly. Twice yearly gives you trend data without over-testing.
- Annually: Deep dive with biological age testing. This is your comprehensive checkup — compare your biological age trajectory year over year.
- After any protocol change: Baseline before starting, then retest at 4–6 weeks and 12 weeks. This is how you know if your intervention is working or causing harm.
The Verdict
Your blood tells you more about how fast you're aging than any biological age test currently available — if you're measuring the right things. Standard bloodwork was designed to detect disease. Longevity bloodwork is designed to detect the drift toward disease years before it arrives.
The markers in this panel aren't exotic or inaccessible. ApoB, fasting insulin, hs-CRP — these are standard laboratory tests that any doctor can order. The problem isn't availability. The problem is that no one tells you to ask for them until you already have a diagnosis.
Don't wait for a diagnosis. Track the numbers. Know your optimal ranges. Let the data drive the interventions. That's what longevity medicine actually looks like — it's not exotic protocols and expensive supplements. It starts with knowing where you stand.
References
- Sniderman AD, et al. "Apolipoprotein B Particles and Cardiovascular Disease: A Narrative Review." JAMA Cardiology. 2019;4(12):1287-1295.
- Ridker PM, et al. "C-Reactive Protein and Other Markers of Inflammation in the Prediction of Cardiovascular Disease in Women." New England Journal of Medicine. 2000;342(12):836-843.
- Wiklund FE, et al. "Macrophage inhibitory cytokine-1 (MIC-1/GDF15): a new marker of all-cause mortality." Aging Cell. 2010;9(6):1057-1064.
- Kraft TS, et al. "The energetics of uniquely human subsistence strategies." Science. 2021;374(6575):eabf0130.
- Attia P. "Outlive: The Science and Art of Longevity." Harmony Books. 2023.
- Camacho-Pereira J, et al. "CD38 Dictates Age-Related NAD Decline." Cell Metabolism. 2016;23(6):1127-1139.
Get the Full Longevity Protocol Stack
Weekly deep-dives on protocols, bloodwork, and the science of aging — delivered every Tuesday.